One of the sure-thing top stories of 2026 will be GLP1s, but will we see more studies and even approval for treating type 1 with these medications?
We’re talking about Ozempic, Mounjaro and the next versions like Retatrutide – that are just around the corner. I’m talking to Dr. Cecelia Lo Wong, a diabetologist at the University of Colorado whose been on the front lines of this conversation for years, including serving on FDA advisory committees.
This is a wide ranging interview – we also talk about the growing needs of older adults with type 1 diabetes, how kidney and cardiovascular risk guidelines are evolving, and why managing diabetes in the hospital can still be such a challenge.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
This week’s Community Commercial is from Lisa Katzenberger, the author of “It Belongs to the World,” a children’s book version of the story of Frederick Banting and the discovery of insulin. Learn more about this book here
Announcing Community Commericals! Learn how to get your message on the show here.
Learn more about studies and research at Thrivable here
Please visit our Sponsors & Partners – they help make the show possible!
Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com)
All about VIVI Cap to protect your insulin from extreme temperatures
The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
Sign up for our newsletter here
Here’s where to find us:
Facebook (Group)
Facebook (Page)
Instagram
Check out Stacey’s books!
Learn more about everything at our home page www.diabetes-connections.com